title: Continuous neostigmine infusion versus bolus neostigmine in refractory Ogilvie syndrome.
authors.affiliation: Department of Internal Medicine, St. Luke's-Roosevelt Hospital Center, Columbia University College of Physicians and Surgeons, New York, NY, USA. luke@kesil.com
authors.forename: Luke
authors.initials: L
authors.lastname: White
authors.forename: Gagangeet
authors.initials: G
authors.lastname: Sandhu
mesh_terms: D002800:Cholinesterase Inhibitors / Q000008:administration & dosage* / Q000627:therapeutic use; D003112:Colonic Pseudo-Obstruction / Q000188:drug therapy*; D006801:Humans; D007262:Infusions, Intravenous; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D009388:Neostigmine / Q000008:administration & dosage* / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D002800:Cholinesterase Inhibitors; D009388:Neostigmine